Last reviewed · How we verify
NCT05762432
Diabetic Foot Ulcer Research Study
NA trial testing Wound Dressing in Diabetic Foot Ulcer in 100 participants. Currently enrolling.
1 December 2026
Quick facts
| Lead sponsor | Community Pharmacology Services Ltd |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 26 April 2024 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 January 2027 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Wound Dressing
- NHS Standard Dressing
Conditions studied
- Diabetic Foot Ulcer — all drugs for Diabetic Foot Ulcer →
- Diabetic Foot Ulcer Neuropathic — all drugs for Diabetic Foot Ulcer Neuropathic →
- Diabetic Foot Ulcer Ischemic — all drugs for Diabetic Foot Ulcer Ischemic →
Sponsor
Community Pharmacology Services Ltd
Who can join
18 and older, any sex, with Diabetic Foot Ulcer or Diabetic Foot Ulcer Neuropathic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare safety and performance of the study device to the current typical NHS standards of care device. The main outcomes it aims to achieve are: Complete wound healing at 12 weeks (100% epithelialised) % Reduction in wound area at 12 weeks Participants will attend their NHS podiatry clinic appointment as normal and will be assigned either the study device or the current typical NHS standard of care device. Researchers will compare the study device group to the standard group to assess the outcomes mentioned previously.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05762432
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Wound Dressing
Trials testing the same drug.
- NCT04918784 — Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers · NA · completed
Other recruiting trials for Diabetic Foot Ulcer
Currently open trials in the same condition.
- NCT07161830 — Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers · NA · recruiting
- NCT07396376 — Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers · Phase 1, PHASE2 · recruiting
- NCT07291817 — Intermittent Negative Pressure for Patients With Diabetic Foot Ulcers (INPRESS) Study · NA · recruiting
- NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
- NCT06938685 — Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers · NA · recruiting
Other Community Pharmacology Services Ltd trials
Trials by the same sponsor.
- NCT06446869 — Menopausal Symptoms Probiotic Study · NA · recruiting
- NCT05903612 — Allergic Bronchopulmonary Aspergillosis Prescreening Study · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05762432 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Community Pharmacology Services Ltd
- Last refreshed: 26 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05762432.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing